UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000022687
Receipt No. R000025927
Official scientific title of the study Delayed type of allergic skin reaction to Candida Albicans in eosinophilic rhinosinusitis cases
Date of disclosure of the study information 2016/06/10
Last modified on 2016/06/10 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Delayed type of allergic skin reaction to Candida Albicans in eosinophilic rhinosinusitis cases
Title of the study (Brief title) Delayed type of allergic skin reaction to Candida Albicans in eosinophilic rhinosinusitis cases
Region
Japan

Condition
Condition Eosinophirilic rinosiusitis.
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Delayed type of allergic skin reaction to Candida Albicans in eosinophilic rhinosinusitis cases
Basic objectives2 Others
Basic objectives -Others pathophysiology of eosinophirilic rinosiusitis.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Recrudescence of postoperative eosinophirilic rinosiusitis at 3 month ago.
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine
Interventions/Control_1 Allergic skin reaction
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Bilateral sinusitis
Key exclusion criteria Cystic disease
Unilateral sinusitis
Fungal rhinosinusitis
Odontogenic sinusitis
Target sample size 50

Research contact person
Name of lead principal investigator Shoji Matsune
Organization Nippon Medical School Musashikosugi Hospital
Division name Department of Otolaryngology
Address 1-369,Kosugithyou,Nakahara-ku,Kanagawa,JAPAN
TEL 044-733-5181
Email sm1988@nms.ac.jp

Public contact
Name of contact person Wakayama Nozomu
Organization Nippon Medical School Musashikosugi Hospital
Division name Department of Otolaryngology
Address 1-369,Kosugithyou,Nakahara-ku,Kanagawa,JAPAN
TEL 044-733-5181
Homepage URL
Email waka84@nms.ac.jp

Sponsor
Institute Nippon Medical School
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Nippon Medical School Musashikosugi Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 06 Month 10 Day

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 05 Month 01 Day
Anticipated trial start date
2012 Year 08 Month 01 Day
Last follow-up date
2015 Year 10 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 06 Month 10 Day
Last modified on
2016 Year 06 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025927